UWI-led research delivers global breakthrough in hypertension management
KINGSTON, Jamaica — Researchers from The University of the West Indies (UWI) have contributed to a landmark international study that could reshape hypertension management in resource-constrained countries, providing new evidence of an effective, affordable and scalable approach to controlling high blood pressure.
The research, conducted through the Caribbean and South American Team-Based Strategy to Control Hypertension (CATCH) Trial, involved investigators from the UWI’s Caribbean Institute for Health Research (CAIHR) and the Department of Community Health and Psychiatry at the Mona Campus.
According to a UWI release on Wednesday, the findings have been published in the prestigious Journal of the American Medical Association (JAMA).
The study offers particularly important implications for the Caribbean, where hypertension remains a major risk factor for heart disease, stroke, kidney disease, dementia and premature death. Its findings demonstrate that combining single-pill blood pressure medication with coordinated, team-based healthcare can significantly improve blood pressure control, providing a practical model for health systems seeking to tackle the region’s growing burden of cardiovascular disease.
Professor Marshall Tulloch-Reid, professor of epidemiology and endocrinology and director of CAIHR, served as Jamaica’s Principal Investigator for the study. He described the research as an important example of how Caribbean-led investigations can contribute to global health solutions.
“We are pleased to be part of this international team of investigators who want to make a difference in hypertension management worldwide and collaborate with the leadership and staff of the Health Departments and the National Health Fund to execute this ground-breaking study. This is the largest study to demonstrate the long-term benefit of single-pill combination blood pressure tablets on blood pressure control and reflects CAIHR’s commitment to engaging in research in the Caribbean that can have global impact,” Professor Tulloch-Reid said.
The findings come at a critical time for Jamaica, where an estimated one in two adults lives with hypertension, yet only approximately one in five achieves adequate blood pressure control.
The economic implications are also considerable. In 2020, the National Health Fund (NHF) estimated that expenditure on subsidised hypertension medications exceeded $1.4 billion. This highlights the need for more effective disease management strategies that can improve health outcomes while supporting efforts to prevent costly cardiovascular complications.
The CATCH Trial enrolled 1,706 adults with uncontrolled hypertension across 40 primary healthcare clinics in Jamaica and Colombia. Participants were randomly assigned to either standard care or an intervention that combined single-pill medications with coordinated, team-based healthcare.
The intervention brought together physicians, nurses and community health workers, supported by health coaching and home blood pressure monitoring, to provide more consistent and structured management of patients’ conditions.
After 18 months, participants receiving the combined intervention achieved substantially better blood pressure outcomes than those receiving standard care.
The study recorded a 10-mmHg difference in average blood pressure between the intervention and standard-care groups. Nearly 70 per cent of participants in the intervention group achieved blood pressure readings below 130/80 mmHg, compared with just 30 per cent of those receiving usual care.
Importantly, the researchers found no difference in serious side effects between the two groups, demonstrating that the intervention was both safe and effective.
A key strength of the research was its implementation within Jamaica’s existing public primary healthcare system. Rather than relying on specialised facilities or entirely new service structures, the intervention was delivered through established healthcare arrangements.
Government-operated pharmacies dispensed the medications, while existing primary healthcare teams coordinated patient care under routine service delivery conditions.
The results were also consistent across urban and rural communities, with no significant differences in outcomes between Jamaica and Colombia, demonstrating the potential for the approach to be adapted and implemented across different healthcare environments.
The university said the CATCH Trial provides compelling evidence in support of integrating single-pill combination therapy with team-based care into hypertension management strategies across the Caribbean and other resource-constrained settings.
It said beyond improving individual patient outcomes, the approach offers health policymakers an opportunity to strengthen primary healthcare delivery, improve medication adherence and make more effective use of existing healthcare resources.
For Caribbean countries facing high rates of hypertension and cardiovascular disease, the findings provide an evidence-based pathway towards improving population health and reducing the long-term consequences of poorly controlled blood pressure.
The CATCH Trial was funded by the United States National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH).